Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Dr. Sabine Ehrt Named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine

Dr. Sabine Ehrt

(New York, April 14, 2025)—Dr. Sabine Ehrt, an internationally renowned leader in tuberculosis research, has been appointed chair of the Department of Microbiology and Immunology at Weill Cornell Medicine, effective July 1.

The department, which is comprised of microbiologists and immunologists, focuses on the body’s interaction with microbes like viruses, bacteria and fungi, along with inflammatory and autoimmune disorders, with a focus on AIDS, malaria and tuberculosis. As chair, Dr. Ehrt seeks to build on the department’s already robust national and international footprint in tuberculosis research and expand its portfolio in other areas of research and innovation. Her goals include bringing on new faculty specializing in antimicrobial resistance and malaria, as well as scientists with skills beyond microbiology or who deploy innovative approaches. She is committed to fostering cross-disciplinary and cross-departmental collaborations, including with the Cornell Center for Antimicrobial Resistance Research and Education and the College of Veterinary Medicine at Cornell’s Ithaca campus. She also wants to boost the mentorship of junior faculty to facilitate their success.

Despite Obstacles, Women Are Uniquely Positioned to Flourish in Medicine

leadership

Thriving as a woman in academic medicine requires blending resilience, authenticity and community while nurturing passions and people, said Dr. Helen W. Boucher, dean of Tufts University School of Medicine and chief academic officer of Tufts Medicine, in her keynote address April 10 for Weill Cornell Medicine’s seventh annual Diversity Week.   

Dr. Boucher, who is also a professor of medicine at Tufts, delivered the Women in Medicine and Science lecture, “Off the Beaten Path: Thriving in Academic Medicine,” in Uris Auditorium. Her speech was part of a series of events to mark Diversity Week, which celebrates Weill Cornell Medicine’s commitment to greater equity, diversity, and inclusion in academic medicine and health care.

Weaving together data and personal reflections, Dr. Boucher contended that while women in medicine have made meaningful progress over the past several decades, significant gaps and challenges remain, from pay inequity to underrepresentation in senior roles. She highlighted the need for multidirectional mentorship as well as the importance of saying yes to opportunities even amid uncertainty.

New Strategy May Enable Cancer Monitoring from Blood Tests Alone

gloved hand holding lab tube

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.

In the study, published Apr. 11 in Nature Methods, the researchers benchmarked the cancer-detection performance of a new commercial sequencing platform from Ultima Genomics. They demonstrated that a low-cost platform such as this one enables a very high “depth” of coverage—a measure of the sequencing data quality—allowing investigators to detect extremely low concentrations of circulating tumor DNA. Adding an error-correcting method greatly improved the accuracy of the technique.

Contact Us